image
Inhibikase Therapeutics, Inc. IKT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.05
-13.1 %
$ 138 M
Market Cap
-0.64
P/E
BALANCE SHEET
14.5 M ASSETS
-41.83%
Growth Rates
1Year -41.83%
3Years -0.63%
5Years 38.50%
7Years 89.89%
10Years 0.00%
3.53 M LIABILITIES
-9.54%
Growth Rates
1Year -9.54%
3Years -10.96%
5Years -0.53%
7Years 12.84%
10Years 0.00%
11 M EQUITY
-47.81%
Growth Rates
1Year -47.81%
3Years 3.91%
5Years 74.35%
7Years 39.19%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Inhibikase Therapeutics, Inc.
image
Current Assets 14.2 M
Cash & Short-Term Investments 13.3 M
Receivables 0
Other Current Assets 959 K
Non-Current Assets 296 K
Long-Term Investments 0
PP&E 296 K
Other Non-Current Assets 0
Current Liabilities 3.44 M
Accounts Payable 647 K
Short-Term Debt 532 K
Other Current Liabilities 2.26 M
Non-Current Liabilities 90.1 K
Long-Term Debt 90.1 K
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
ASSETS
Cash & Cash Equivalents 9.2 7.2 40.8 14.0 18.5 K 0.4 16.7 K 12 K
Short Term Investments 4.1 15.9 0 0 0 0 0 0
Receivables 0 39.9 K 0.1 0 0 0.5 0.2 66.9 K
Inventory 0 1.1 0.1 0 0 0 0 0
Other Current Assets 1.0 1.3 1.6 0.8 16.9 K 0.4 625 1.25 K
Total Current Assets 14.2 24.4 42.5 14.8 35.4 K 1.3 0.2 80.2 K
PP&E 0.3 0.6 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0
Long Term Investments 0 (15.8) 0 0 0 0 87.1 K 0
Other Long Term Assets 0 15.8 0 0 2.87 K 1.6 0 82.8 K
Other Assets 0 0 1.6 0.8 0 0 0 0
Total Assets 14.5 24.9 42.5 14.8 38.3 K 2.8 0.3 0.2
LIABILITIES
Accounts Payable 0.6 1.2 1.1 1.7 1.0 1.0 0.4 0.4
Short Term Debt 0.5 0.3 0.2 42.5 K 98.4 K 0.2 0.5 0.3
Other Current Liabilities 2.3 2.3 2.7 0.6 1.7 2.2 0.9 0.8
Total Current Liabilities 3.4 3.7 4.1 4.7 4.3 3.6 1.7 1.5
Long Term Debt 90.1 K 0.2 0 0.3 0.3 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0
Total Liabilities 3.5 3.9 4.1 5.0 4.5 3.6 1.7 1.5
EQUITY
Common Stock 6.19 K 25.2 K 25.2 K 10.1 K 8.18 K 8.18 K 8.92 K 8.92 K
Retained Earnings (66.9) (47.9) (29.8) (15.0) (12.2) (6.5) (4.3) (3.9)
Other Accumulative Comprehensive Income/Loss 877 0.1 0 0 0 0 0 0
Total Equity 11.0 21.0 38.4 9.8 (4.5) (0.8) (1.4) (1.4)
Total Liabilities and Equity 14.5 24.9 42.5 14.8 38.3 K 2.8 0.3 0.2
SHARES OUTSTANDING
Common Shares Outstanding 5.3 4.2 3.0 1.7 1.7 1.3 1.7 1.3